Clinical Research Directory
Browse clinical research sites, groups, and studies.
Vaccination Against Influenza Pre-discharge in Heart Failure
Sponsor: Wroclaw Medical University
Summary
In patients with heart failure (HF), influenza vaccination should be considered to prevent HF hospitalizations. However, vaccination rates among patients with HF are low, in part because of subjective but common concerns about whether patients with such severe disease should be vaccinated. In this randomized, open-label study, we will investigate whether influenza vaccination before discharge in patients stabilized after cardiac decompensation is safe and improves outcomes over a 6-month follow-up period.
Official title: Vaccination Against Influenza Pre-discharge in Patients Hospitalized Due to Heart Failure
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2024-12-31
Completion Date
2025-12
Last Updated
2025-07-23
Healthy Volunteers
No
Conditions
Interventions
Influenza vaccination
Influenza vaccination pre-discharge in patients hospitalized due to heart failure exacerbation
Locations (1)
Jan Mikulicz Radecki University Hospital in Wroclaw
Wroclaw, Lower Silesian Voivodeship, Poland